New Zealand markets closed

Gritstone bio, Inc. (GRTS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.8129+0.0743 (+10.06%)
At close: 04:00PM EDT
0.8199 +0.01 (+0.86%)
After hours: 07:11PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 78.59M
Enterprise value 104.09M
Trailing P/E 0.60
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)64.11
Price/book (mrq)1.52
Enterprise value/revenue 78.20
Enterprise value/EBITDA -0.82

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-68.91%
S&P500 52-week change 325.01%
52-week high 33.3300
52-week low 30.6700
50-day moving average 31.9290
200-day moving average 31.9237

Share statistics

Avg vol (3-month) 32.95M
Avg vol (10-day) 33.63M
Shares outstanding 5106.4M
Implied shares outstanding 6106.4M
Float 890.55M
% held by insiders 12.30%
% held by institutions 140.36%
Shares short (28 Mar 2024) 49.12M
Short ratio (28 Mar 2024) 44.95
Short % of float (28 Mar 2024) 410.49%
Short % of shares outstanding (28 Mar 2024) 49.30%
Shares short (prior month 29 Feb 2024) 48.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-293.47%

Management effectiveness

Return on assets (ttm)-41.70%
Return on equity (ttm)-124.41%

Income statement

Revenue (ttm)16.34M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)143.60%
Gross profit (ttm)N/A
EBITDA -132.03M
Net income avi to common (ttm)-138.49M
Diluted EPS (ttm)-1.2000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)79.27M
Total cash per share (mrq)0.81
Total debt (mrq)104.78M
Total debt/equity (mrq)202.07%
Current ratio (mrq)3.20
Book value per share (mrq)0.53

Cash flow statement

Operating cash flow (ttm)-121.65M
Levered free cash flow (ttm)-79.98M